Related Experiment Video

Updated: Jul 9, 2025

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

447

Chinese expert consensus on the overall management of liver function in conversion therapy for liver cancer (2022

Qinghua Meng1, Zhengqiang Yang2, Zhenyu Zhu3

  • 1Department of Hepatology, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China.

Chinese Medical Journal
|November 29, 2023
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula
09:03

Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula

Published on: January 26, 2024

365
A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

5.2K

Related Experiment Videos

Last Updated: Jul 9, 2025

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

447
Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula
09:03

Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula

Published on: January 26, 2024

365
A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

5.2K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

92
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
92

Articles linked to this work by shared authors, journal, and citation graph.

Patient Characteristics and Treatment Patterns of Advanced Biliary Tract Cancer (BTC): A Chinese Physician Survey.

Advances in therapy·2026

Chinese expert consensus on precision testing and molecular diagnosis of pancreatic cancer (2025).

British journal of cancer·2026

Biliary drainage plus hepatic arterial infusion chemotherapy versus biliary drainage plus best supportive care for advanced perihilar cholangiocarcinoma in China: a prospective multicentre non-randomised controlled study.

EClinicalMedicine·2026

MICLEAR: Intelligent molecular cytology for intraoperative margin assessment of pancreatic ductal adenocarcinoma.

Medical image analysis·2026

PET radiotracers targeting MDM2 protein interaction: From preclinical validation to first-in-human studies.

Pharmacological research·2026

Chinese expert consensus on conversion and perioperative therapy of primary liver cancer (2024 edition).

Hepatobiliary surgery and nutrition·2026

Interleukin-33 alleviates the immunosuppressive tumor microenvironment and enhances anti-programmed death ligand-1 immunotherapy efficacy in hepatocellular carcinoma.

Chinese medical journal·2026

Extracellular vesicles as biomarkers and therapeutic nanocarriers in cancer.

Chinese medical journal·2026

HMGB1 induces mitochondrial dysfunction through the TLR4 and RAGE pathways to promote astrocyte autophagy and PANoptosis in intracerebral hemorrhage.

Chinese medical journal·2026

BAP31 attenuates acute lung injury by inhibiting ferroptosis through activation of the AKT/GSK3β/Nrf2 pathway in the alveolar epithelial cells.

Chinese medical journal·2026

Bacteriophages in humans: From discovery and mechanisms to therapeutic promise in combating disease.

Chinese medical journal·2026

Advancements and future directions in transforming therapies of prostate cancer.

Chinese medical journal·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us